Compugen Ltd.
(NASDAQ : CGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
3.33%202.101.2%$536.25m
GILDGilead Sciences, Inc.
4.69%76.190.9%$481.31m
BIIBBiogen Inc.
2.83%337.711.3%$395.55m
CELGCelgene Corporation
2.93%84.231.2%$349.13m
ILMNIllumina, Inc.
4.06%326.123.5%$309.72m
REGNRegeneron Pharmaceuticals, Inc.
5.50%398.332.6%$241.06m
ALXNAlexion Pharmaceuticals, Inc.
4.98%127.542.0%$225.79m
VRTXVertex Pharmaceuticals Incorporated
4.25%185.201.9%$219.43m
SRPTSarepta Therapeutics, Inc.
5.12%138.0616.4%$179.87m
AAgilent Technologies, Inc.
2.80%67.471.5%$161.89m
BMRNBioMarin Pharmaceutical Inc.
6.41%105.824.4%$144.04m
LGNDLigand Pharmaceuticals Incorporated
5.90%211.8823.3%$122.17m
VKTXViking Therapeutics, Inc.
6.74%15.160.9%$119.61m
NKTRNektar Therapeutics
2.57%50.345.6%$111.85m
EXASExact Sciences Corporation
2.93%67.7025.3%$106.04m

Company Profile

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.